STEELE GLENN JR MD PHD bought PTCT
September 30, 2026 · Form 4 insider transaction
STEELE GLENN JR MD PHD bought 12,000 shares of PTC Therapeutics, Inc. at $11.23 per share, a transaction worth $134.8K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
12,000
Price
$11.23
Total value
$134.8K
InsiderSTEELE GLENN JR MD PHD
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 30, 2026
Filing dateOctober 2, 2026
Shares owned after34,500
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 9, 2026